Research ArticleInnate Immunity
HIPK2 is necessary for type I interferon–mediated antiviral immunity
- Lili Cao1,*,
- Guang Yang2,3,*,
- Shandian Gao2,
- Chunxia Jing4,
- Ruth R. Montgomery5,
- Yuxin Yin1,
- Penghua Wang2,6,
- Erol Fikrig2,7,†, and
- Fuping You1,†
- 1Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing 100191, China.
- 2Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 208022, USA.
- 3Department of Parasitology, Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, No. 601, Huangpu Avenue West, Guangzhou, Guangdong 510632, China.
- 4Department of Epidemiology, School of Medicine, Jinan University, Guangzhou 510632, China.
- 5Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06510, USA.
- 6Department of Immunology, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT 06030, USA.
- 7Howard Hughes Medical Institute, Chevy Chase, MA 20815, USA.
- ↵†Corresponding author. Email: fupingyou{at}hsc.pku.edu.cn (F.Y.); erol.fikrig{at}yale.edu (E.F.)
See allHide authors and affiliations
Science Signaling 19 Mar 2019:
Vol. 12, Issue 573, eaau4604
DOI: 10.1126/scisignal.aau4604
